サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1279738

静脈内溶液の世界市場規模調査＆予測：溶液組成別、タイプ別、地域別分析、2022-2029年

Global Intravenous Solutions Market Size study & Forecast, by Type by Solution Composition and Regional Analysis, 2022-2029

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
静脈内溶液の世界市場規模調査＆予測：溶液組成別、タイプ別、地域別分析、2022-2029年
出版日: 2023年05月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈内溶液は、静脈を通して患者さんの血流に直接投与される滅菌された液体です。

病院や診療所などの医療現場で、経口摂取が困難な患者さんに水分補給や薬物、栄養素、その他の治療薬を提供するために一般的に使用されています。輸液には、患者さんのニーズに応じて、水、電解質、糖質、ビタミン、薬剤などを様々に組み合わせて使用します。輸液には、等張、低張、高張などの濃度や種類があり、体液バランスへの影響を決定します。市場成長の主な要因は、栄養失調の有病率の上昇であり、患者の利便性を高める製品の進歩や新しいイノベーションが、予測期間中の市場成長をサポートすると予想されます。

さらに、点滴が患者の一次エネルギー源となる消化器疾患、神経疾患、がんなどの疾患の流行は、市場成長の主な貢献要因の1つとなっています。世界保健機関（WHO）によると、2019年の死亡者数は37万人で、下痢は5歳未満の子どもの2番目に多い死因となっています。また、ポータブルパッケージのソリューションが利用できるため、患者が病院ではなく自宅で簡単に点滴を使用できることや、利便性の向上とパッケージの廃棄量を減らすためのプレミックスソリューションなどの製品イノベーションは、市場の成長を後押しするその他の要因の一部です。例えば、2019年6月には、特殊輸液や医薬品を製造・販売するユーロライフ・ヘルスケア社が、使い勝手が良く感染症対策にもなる静脈内点滴装置「ディスクポート」と「ライフポート」を発表しています。さらに、老年人口の増加は、予測期間中に市場に有利な機会を生み出すと予想されます。しかし、経験豊富なヘルスケア専門家の不足と静脈内投与療法の合併症が、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

世界の静脈内溶液市場の調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカ、世界のその他の地域です。北米は、主要な市場プレイヤーの存在と、同地域の高齢者人口の増加により、市場シェアにおいて世界の主要な地域となっています。一方、アジア太平洋地域は、慢性疾患の有病率の上昇、利害関係者間の協力関係の増加、老齢人口の増加などの要因から、予測期間中に高い成長率を示すと予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2019年～2029年
    • 静脈内溶液市場、地域別、2019年～2029年
    • 静脈内溶液市場：タイプ別、2019年～2029年
    • 静脈内溶液市場：溶液組成別、2019年～2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 静脈内溶液の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 本調査の対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 静脈内溶液の世界市場力学

  • 静脈内溶液の市場の影響分析（2019年～2029年）
    • 市場促進要因
      • 栄養失調の有病率の上昇
      • 患者の利便性を高めるための製品の進歩や新たなイノベーション
    • 市場の課題
      • 経験豊富なヘルスケア専門家の不足
      • 静脈内投与療法における合併症
    • 市場参入の可能性
      • 老年人口の増加

第4章 世界の静脈内溶液市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 主な投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19の影響

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 静脈内溶液の世界市場、タイプ別

  • 市場スナップショット
  • 静脈内溶液の世界市場：タイプ別、実績-ポテンシャル分析
  • 静脈内溶液の世界市場、タイプ別、推定・予測2019～2029年
  • 静脈内溶液市場、サブセグメント別分析
    • 総合非経口栄養剤
    • ペリフェラル非経口栄養

第7章 静脈内溶液の世界市場：溶液組成別

  • 市場スナップショット
  • 静脈内溶液の世界市場：溶液組成別、実績 - ポテンシャル分析
  • 静脈内溶液の世界市場、溶液組成別、推定・予測2019年～2029年
  • 静脈内溶液の市場、サブセグメント別分析
    • 生理食塩水
    • 炭水化物
    • ビタミン・ミネラル
    • その他の溶液組成物

第8章 静脈内溶液の世界市場：地域別分析

  • 静脈内溶液の市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • 溶液組成別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の静脈内溶液市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の静脈内溶液市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの静脈内溶液市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Amanta Healthcare Ltd.
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Axa Parenterals Ltd.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Dickinson and Company
    • Eurolife Healthcare Pvt Ltd.
    • Fresenius Kabi AG
    • Grifols S.A
    • Henry Schein Inc.
    • ICU Medical, Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Intravenous Solutions Market, report scope
  • TABLE 2. Global Intravenous Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Intravenous Solutions Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Intravenous Solutions Market estimates & forecasts by Solution Composition 2019-2029 (USD Billion)
  • TABLE 5. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Intravenous Solutions Market
  • TABLE 70. List of primary sources, used in the study of global Intravenous Solutions Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Intravenous Solutions Market, research methodology
  • FIG 2. Global Intravenous Solutions Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Intravenous Solutions Market, key trends 2021
  • FIG 5. Global Intravenous Solutions Market, growth prospects 2022-2029
  • FIG 6. Global Intravenous Solutions Market, porters 5 force model
  • FIG 7. Global Intravenous Solutions Market, pest analysis
  • FIG 8. Global Intravenous Solutions Market, value chain analysis
  • FIG 9. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Intravenous Solutions Market, regional snapshot 2019 & 2029
  • FIG 15. North America Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Intravenous Solutions Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.

Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.

Major market players included in this report are:

  • Amanta Healthcare Ltd.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dickinson and Company
  • Eurolife Healthcare Pvt Ltd.
  • Fresenius Kabi AG
  • Grifols S.A
  • Henry Schein Inc.
  • ICU Medical, Inc.

Recent Developments in the Market:

  • In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.

Global Intravenous Solutions Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Solution Composition, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

By Solution Composition:

  • Saline
  • Carbohydrates
  • Vitamins and Minerals
  • Other Solution Compositions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Intravenous Solutions Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Intravenous Solutions Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Intravenous Solutions Market, by Solution Composition, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Intravenous Solutions Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Intravenous Solutions Market Dynamics

  • 3.1. Intravenous Solutions Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in prevalence of malnutrition
      • 3.1.1.2. Advancements and new innovations in the products for patient convenience
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of experienced healthcare professionals
      • 3.1.2.2. Complications of intravenous administration therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing geriatric population

Chapter 4. Global Intravenous Solutions Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Intravenous Solutions Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Intravenous Solutions Market by Type, Performance - Potential Analysis
  • 6.3. Global Intravenous Solutions Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Intravenous Solutions Market, Sub Segment Analysis
    • 6.4.1. Total Parenteral Nutrition
    • 6.4.2. Peripheral Parenteral Nutrition

Chapter 7. Global Intravenous Solutions Market, by Solution Composition

  • 7.1. Market Snapshot
  • 7.2. Global Intravenous Solutions Market by Solution Composition, Performance - Potential Analysis
  • 7.3. Global Intravenous Solutions Market Estimates & Forecasts by Solution Composition 2019-2029 (USD Billion)
  • 7.4. Intravenous Solutions Market, Sub Segment Analysis
    • 7.4.1. Saline
    • 7.4.2. Carbohydrates
    • 7.4.3. Vitamins and Minerals
    • 7.4.4. Other Solution Compositions

Chapter 8. Global Intravenous Solutions Market, Regional Analysis

  • 8.1. Intravenous Solutions Market, Regional Market Snapshot
  • 8.2. North America Intravenous Solutions Market
    • 8.2.1. U.S. Intravenous Solutions Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Solution Composition breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Intravenous Solutions Market
  • 8.3. Europe Intravenous Solutions Market Snapshot
    • 8.3.1. U.K. Intravenous Solutions Market
    • 8.3.2. Germany Intravenous Solutions Market
    • 8.3.3. France Intravenous Solutions Market
    • 8.3.4. Spain Intravenous Solutions Market
    • 8.3.5. Italy Intravenous Solutions Market
    • 8.3.6. Rest of Europe Intravenous Solutions Market
  • 8.4. Asia-Pacific Intravenous Solutions Market Snapshot
    • 8.4.1. China Intravenous Solutions Market
    • 8.4.2. India Intravenous Solutions Market
    • 8.4.3. Japan Intravenous Solutions Market
    • 8.4.4. Australia Intravenous Solutions Market
    • 8.4.5. South Korea Intravenous Solutions Market
    • 8.4.6. Rest of Asia Pacific Intravenous Solutions Market
  • 8.5. Latin America Intravenous Solutions Market Snapshot
    • 8.5.1. Brazil Intravenous Solutions Market
    • 8.5.2. Mexico Intravenous Solutions Market
    • 8.5.3. Rest of Latin America Intravenous Solutions Market
  • 8.6. Rest of The World Intravenous Solutions Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Amanta Healthcare Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Axa Parenterals Ltd.
    • 9.2.3. B. Braun Melsungen AG
    • 9.2.4. Baxter International Inc.
    • 9.2.5. Dickinson and Company
    • 9.2.6. Eurolife Healthcare Pvt Ltd.
    • 9.2.7. Fresenius Kabi AG
    • 9.2.8. Grifols S.A
    • 9.2.9. Henry Schein Inc.
    • 9.2.10. ICU Medical, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption